FDA Will Take GMP Inspections To The Next Level
This article was originally published in The Tan Sheet
Executive Summary
If supplement firms thought FDA inspectors were tough on GMP compliance last year – they ain’t seen nothing yet. FDA investigators are ready to delve into more complex and technical GMP areas after focusing primarily on “surface level areas of GMP compliance” to date, FDA officials warn.
You may also be interested in...
Promise Of A New Day For Rx-To-OTC Switch Ruled 2012 In “The Tan Sheet”
The most popular stories in “The Tan Sheet” during 2012 dealt with FDA’s nonprescription safe use regulatory extension initiative, as well as planned switches by Pfizer and Merck. In dietary supplements, coverage of firms struggling with GMPs and congressional threats to DSHEA drew the most interest.
Promise Of A New Day For Rx-To-OTC Switch Ruled 2012 In “The Tan Sheet”
The most popular stories in “The Tan Sheet” during 2012 dealt with FDA’s nonprescription safe use regulatory extension initiative, as well as planned switches by Pfizer and Merck. In dietary supplements, coverage of firms struggling with GMPs and congressional threats to DSHEA drew the most interest.
Senators Ask Why GMP Compliance Eludes Dietary Supplement Firms
Democrats Durbin and Blumenthal raise concerns about the “pervasiveness of poor manufacturing standards” in the supplement industry and demand to know what trade groups will do to improve compliance with good manufacturing practices.